205 related articles for article (PubMed ID: 20130594)
1. Soluble adenylyl cyclase defines a nuclear cAMP microdomain in keratinocyte hyperproliferative skin diseases.
Zippin JH; Chadwick PA; Levin LR; Buck J; Magro CM
J Invest Dermatol; 2010 May; 130(5):1279-87. PubMed ID: 20130594
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases.
Piepkorn M
Am J Dermatopathol; 1996 Apr; 18(2):165-71. PubMed ID: 8739992
[TBL] [Abstract][Full Text] [Related]
3. Bicarbonate-responsive "soluble" adenylyl cyclase defines a nuclear cAMP microdomain.
Zippin JH; Farrell J; Huron D; Kamenetsky M; Hess KC; Fischman DA; Levin LR; Buck J
J Cell Biol; 2004 Feb; 164(4):527-34. PubMed ID: 14769862
[TBL] [Abstract][Full Text] [Related]
4. Soluble adenylyl cyclase contributes to imiquimod-mediated inflammation and is a potential therapeutic target in psoriasis.
You J; Reilly MD; Eljalby M; Bareja R; Yusupova M; Vyas NS; Bang J; Ding W; Desman G; Miller LS; Elemento O; Granstein RD; Zippin JH
Exp Dermatol; 2023 Jul; 32(7):1051-1062. PubMed ID: 37039485
[TBL] [Abstract][Full Text] [Related]
5. Soluble adenylyl cyclase in vascular endothelium: gene expression control of epithelial sodium channel-α, Na+/K+-ATPase-α/β, and mineralocorticoid receptor.
Schmitz B; Nedele J; Guske K; Maase M; Lenders M; Schelleckes M; Kusche-Vihrog K; Brand SM; Brand E
Hypertension; 2014 Apr; 63(4):753-61. PubMed ID: 24420537
[TBL] [Abstract][Full Text] [Related]
6. Soluble adenylyl cyclase links Ca
Parker T; Wang KW; Manning D; Dart C
Sci Rep; 2019 May; 9(1):7317. PubMed ID: 31086231
[TBL] [Abstract][Full Text] [Related]
7. Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice.
Koegel H; von Tobel L; Schäfer M; Alberti S; Kremmer E; Mauch C; Hohl D; Wang XJ; Beer HD; Bloch W; Nordheim A; Werner S
J Clin Invest; 2009 Apr; 119(4):899-910. PubMed ID: 19307725
[TBL] [Abstract][Full Text] [Related]
8. Role of soluble adenylyl cyclase in cell death and growth.
Ladilov Y; Appukuttan A
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt B):2646-55. PubMed ID: 25010002
[TBL] [Abstract][Full Text] [Related]
9. Intracellular cAMP signaling by soluble adenylyl cyclase.
Tresguerres M; Levin LR; Buck J
Kidney Int; 2011 Jun; 79(12):1277-88. PubMed ID: 21490586
[TBL] [Abstract][Full Text] [Related]
10. Pulsed electromagnetic fields promote bone formation by activating the sAC-cAMP-PKA-CREB signaling pathway.
Wang YY; Pu XY; Shi WG; Fang QQ; Chen XR; Xi HR; Gao YH; Zhou J; Xian CJ; Chen KM
J Cell Physiol; 2019 Mar; 234(3):2807-2821. PubMed ID: 30067871
[TBL] [Abstract][Full Text] [Related]
11. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
[TBL] [Abstract][Full Text] [Related]
12. From membrane to nucleus: A three-wave hypothesis of cAMP signaling.
Pizzoni A; Zhang X; Altschuler DL
J Biol Chem; 2024 Jan; 300(1):105497. PubMed ID: 38016514
[TBL] [Abstract][Full Text] [Related]
13. Soluble adenylyl cyclase mediates nerve growth factor-induced activation of Rap1.
Stessin AM; Zippin JH; Kamenetsky M; Hess KC; Buck J; Levin LR
J Biol Chem; 2006 Jun; 281(25):17253-17258. PubMed ID: 16627466
[TBL] [Abstract][Full Text] [Related]
14. Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation.
Ruchusatsawat K; Wongpiyabovorn J; Protjaroen P; Chaipipat M; Shuangshoti S; Thorner PS; Mutirangura A
Hum Pathol; 2011 Dec; 42(12):1878-87. PubMed ID: 21663940
[TBL] [Abstract][Full Text] [Related]
15. The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-kappaB in HaCaT keratinocytes.
Qi XF; Kim DH; Yoon YS; Li JH; Song SB; Jin D; Huang XZ; Teng YC; Lee KJ
Mol Immunol; 2009 Jun; 46(10):1925-34. PubMed ID: 19371952
[TBL] [Abstract][Full Text] [Related]
16. Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cells.
Flacke JP; Flacke H; Appukuttan A; Palisaar RJ; Noldus J; Robinson BD; Reusch HP; Zippin JH; Ladilov Y
J Biol Chem; 2013 Feb; 288(5):3126-35. PubMed ID: 23255611
[TBL] [Abstract][Full Text] [Related]
17. Soluble adenylyl cyclase controls mitochondria-dependent apoptosis in coronary endothelial cells.
Kumar S; Kostin S; Flacke JP; Reusch HP; Ladilov Y
J Biol Chem; 2009 May; 284(22):14760-8. PubMed ID: 19336406
[TBL] [Abstract][Full Text] [Related]
18. Tenascin expression in hyperproliferative skin diseases.
Schalkwijk J; Van Vlijmen I; Oosterling B; Perret C; Koopman R; Van den Born J; Mackie EJ
Br J Dermatol; 1991 Jan; 124(1):13-20. PubMed ID: 1704250
[TBL] [Abstract][Full Text] [Related]
19. Bicarbonate-sensing soluble adenylyl cyclase is present in the cell cytoplasm and nucleus of multiple shark tissues.
Roa JN; Tresguerres M
Physiol Rep; 2017 Jan; 5(2):. PubMed ID: 28108644
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological modulation of the CO
Wiggins SV; Steegborn C; Levin LR; Buck J
Pharmacol Ther; 2018 Oct; 190():173-186. PubMed ID: 29807057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
